Healthcare Triangle (NASDAQ:HCTI – Get Free Report) and Nyxoah (NASDAQ:NYXH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.
Valuation and Earnings
This table compares Healthcare Triangle and Nyxoah”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Healthcare Triangle | $11.70 million | 0.06 | -$5.97 million | ($6,047.90) | 0.00 |
| Nyxoah | $4.89 million | 32.46 | -$64.10 million | ($2.49) | -1.87 |
Profitability
This table compares Healthcare Triangle and Nyxoah’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Healthcare Triangle | -48.85% | N/A | -59.99% |
| Nyxoah | -1,457.97% | -101.99% | -66.74% |
Institutional & Insider Ownership
0.3% of Healthcare Triangle shares are held by institutional investors. 0.1% of Healthcare Triangle shares are held by company insiders. Comparatively, 17.1% of Nyxoah shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of current recommendations for Healthcare Triangle and Nyxoah, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Healthcare Triangle | 1 | 0 | 0 | 0 | 1.00 |
| Nyxoah | 1 | 0 | 3 | 0 | 2.50 |
Nyxoah has a consensus target price of $11.67, indicating a potential upside of 150.36%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Healthcare Triangle.
Risk and Volatility
Healthcare Triangle has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500.
About Healthcare Triangle
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company’s software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. It primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. The company was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. is a subsidiary of SecureKloud Technologies, Inc.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Receive News & Ratings for Healthcare Triangle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Triangle and related companies with MarketBeat.com's FREE daily email newsletter.
